$KURA News

Kura Oncology Highlights New Clinical And Translational Data Supporting Darlifarnib As Potential Foundational Combination Platform For KRAS-Mutant Cancers And Other Targeted Therapy Settings

Kura Oncology And Kyowa Kirin Announce Blood Publication Of Phase 1 Ziftomenib Combination Data Showing 87% ORR In Venetoclax-Naïve R/R NPM1-m AML

Kura Oncology Announces First-In-Human Data From The FIT-001 Clinical Trial Of Darlifarnib In Combination With Adagrasib In Heavily Pretreated Patients With KRAS G12C-Mutated Advanced Solid Tumors

Kura Oncology, Inc. (KURA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kura Oncology, Inc. (KURA) Q1 2026 Earnings Call Transcript

Kura Oncology (NASDAQ:KURA) Slips After Q1 Earnings Miss

Kura Oncology Q1 EPS $(0.83) Beats $(0.94) Estimate, Sales $18.265M Miss $18.513M Estimate

Kura Oncology Announces Acceptance Of Its Updated Results From Phase 1 KOMET-007 Clinical Study Of Ziftomenib In Combination With Cytarabine Plus Daunorubicin For Presentation At 2026 European Hematology Association Congress

Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know

Kura Oncology to Report First Quarter 2026 Financial Results

How The Kura Oncology (KURA) Story Is Evolving After Komzifti Launch And Q4 Reassessment

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Kyowa Kirin And Kura Oncology Announce First Patient Dosed In Japanese Phase 2 Registrational Clinical Trial Studying Ziftomenib For Treatment Of R/R NPM1-Mutated Acute Myeloid Leukemia

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma - Slideshow

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data

Kura Oncology: Poised For A Lift With Combinations

How The Kura Oncology (KURA) Narrative Is Shifting With Komzifti Launch And New Analyst Targets